<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Sinus node dysfunction (SND) commonly manifests with atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> alternating with sinus pauses and <z:hpo ids='HP_0001688'>sinus bradycardia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The underlying process is thought to be because of atrial <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We assessed the value of atrial <z:mp ids='MP_0003045'>fibrosis</z:mp>, quantified using late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhanced-MRI (LGE-MRI), in predicting significant SND requiring pacemaker implant </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Three hundred forty-four patients with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) presenting for catheter ablation underwent LGE-MRI </plain></SENT>
<SENT sid="4" pm="."><plain>Left atrial (LA) <z:mp ids='MP_0003045'>fibrosis</z:mp> was quantified in <z:hpo ids='HP_0000001'>all</z:hpo> patients and right atrial (RA) <z:mp ids='MP_0003045'>fibrosis</z:mp> in 134 patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent catheter ablation with pulmonary vein isolation with posterior wall and septal debulking </plain></SENT>
<SENT sid="6" pm="."><plain>Patients were followed prospectively for 329 ± 245 days </plain></SENT>
<SENT sid="7" pm="."><plain>Ambulatory monitoring was instituted every 3 months </plain></SENT>
<SENT sid="8" pm="."><plain>Symptomatic pauses and <z:hpo ids='HP_0001662'>bradycardia</z:hpo> were treated with pacemaker implantation per published guidelines </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: The average patient age was 65 ± 12 years </plain></SENT>
<SENT sid="10" pm="."><plain>The average wall <z:mp ids='MP_0003045'>fibrosis</z:mp> was 16.7 ± 11.1% in the LA, and 5.3 ± 6.4% in the RA </plain></SENT>
<SENT sid="11" pm="."><plain>RA <z:mp ids='MP_0003045'>fibrosis</z:mp> was correlated with LA <z:mp ids='MP_0003045'>fibrosis</z:mp> (R(2) = 0.26; P &lt; 0.01) </plain></SENT>
<SENT sid="12" pm="."><plain>Patients were divided into 4 stages of LA <z:mp ids='MP_0003045'>fibrosis</z:mp> (Utah I: &lt;5%, Utah II: 5-20%, Utah III: 20-35%, Utah IV: &gt;35%) </plain></SENT>
<SENT sid="13" pm="."><plain>Twenty-two patients (mean atrial <z:mp ids='MP_0003045'>fibrosis</z:mp>, 23.9%) required pacemaker implantation during follow-up </plain></SENT>
<SENT sid="14" pm="."><plain>Univariate and multivariate analysis identified LA <z:mp ids='MP_0003045'>fibrosis</z:mp> stage (OR, 2.2) as a significant predictor for pacemaker implantation with an area under the curve of 0.704 </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: In patients with AF presenting for catheter ablation, LGE-MRI quantification of atrial <z:mp ids='MP_0003045'>fibrosis</z:mp> demonstrates preferential LA involvement </plain></SENT>
<SENT sid="16" pm="."><plain>Significant atrial <z:mp ids='MP_0003045'>fibrosis</z:mp> is associated with clinically significant SND requiring pacemaker implantation </plain></SENT>
</text></document>